SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-240629
Filing Date
2022-09-08
Accepted
2022-09-08 08:48:04
Documents
16
Period of Report
2022-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d364568d8k.htm   iXBRL 8-K 32034
2 EX-1.1 d364568dex11.htm EX-1.1 234095
3 EX-5.1 d364568dex51.htm EX-5.1 8313
8 GRAPHIC g364568dsp1.jpg GRAPHIC 7728
  Complete submission text file 0001193125-22-240629.txt   511302

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA celu-20220908.xsd EX-101.SCH 3111
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220908_def.xml EX-101.DEF 13640
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220908_lab.xml EX-101.LAB 22556
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220908_pre.xml EX-101.PRE 14458
10 EXTRACTED XBRL INSTANCE DOCUMENT d364568d8k_htm.xml XML 5407
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 221232640
SIC: 2834 Pharmaceutical Preparations